Søren T. Hoff

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

Patricia A. Darrah, Dipti T. Patel, Paula Mello De Luca et al. · Nature Medicine · 2007 · 1.4K citations

Life Sciences, Immunology, Infectious Diseases +14

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

Richard E. Pratley, Aslam Amod, Søren T. Hoff et al. · The Lancet · 2019 · 583 citations

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

Bernard Zinman, Vanita R. Aroda, John B. Buse et al. · Diabetes Care · 2019 · 282 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human

Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff et al. · Vaccine · 2014 · 243 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Angelique Kany Kany Luabeya, Benjamin M. Kagina, Michèle Tameris et al. · Vaccine · 2015 · 194 citations

Veterinary Medicine, Immunology, Infectious Diseases +15